Home » Stocks » Thermo Fisher Scientific

Thermo Fisher Scientific, Inc. (TMO)

Stock Price: $481.99 USD 13.23 (2.82%)
Updated Oct 22, 2020 4:00 PM EDT - Market closed
After-hours: $484.00 +2.01 (0.42%) Oct 22, 7:26 PM

Stock Price Chart

Key Info

Market Cap 190.67B
Revenue (ttm) 26.25B
Net Income (ttm) 3.71B
Shares Out 395.59M
EPS (ttm) 12.19
PE Ratio 39.54
Forward PE 26.11
Dividend $0.88
Dividend Yield 0.18%

Stock Quote

Trading Day Oct 22, 2020
Last Price $481.99
Previous Close $468.76
Change ($) 13.23
Change (%) 2.82%
Day's Open 471.69
Day's Range 470.11 - 485.00
Day's Volume 1,454,628
52-Week Range 250.21 - 485.00

More Stats

Market Cap 190.67B
Enterprise Value 206.16B
Earnings Date (est) Feb 4, 2021
Ex-Dividend Date Sep 14, 2020
Shares Outstanding 395.59M
Float 394.78M
EPS (basic) 9.31
EPS (diluted) 12.19
FCF / Share 10.82
Dividend $0.88
Dividend Yield 0.18%
Earnings Yield 2.53%
FCF Yield 2.24%
Payout Ratio 8.80%
Shares Short 2.37M
Short Ratio 1.68
Short % of Float 0.60%
Beta 0.99
PE Ratio 39.54
Forward PE 26.11
P/FCF Ratio 44.60
PS Ratio 7.26
PB Ratio 6.15
Revenue 26.25B
Operating Income 4.48B
Net Income 3.71B
Free Cash Flow 4.28B
Net Cash -15.50B
Net Cash / Share -39.17
Gross Margin 39.81%
Operating Margin 17.05%
Profit Margin 14.10%
FCF Margin 16.29%
ROA 6.27%
ROE 15.95%
ROIC 16.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (21)

Buy 15
Overweight 2
Hold 3
Underweight 1
Sell 0

Analyst Consensus: Buy

Price Target

(5.45% upside)
Current: $481.99
Target: 508.28
*Average 12-month price target from 18 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth4.86%16.45%14.47%7.72%0.45%29.02%4.64%8.23%11.22%-
Gross Profit11,32810,8579,4488,3727,7567,4925,5295,2964,7944,262
Operating Income4,5943,7832,9602,4582,3362,5031,6101,4821,2511,188
Net Income3,6962,9382,2252,0221,9751,8941,2731,1781,3301,036
Shares Outstanding400402395395399398360364381403
Earnings Per Share9.177.245.595.094.924.713.483.213.462.53
EPS Growth26.66%29.52%9.82%3.46%4.46%35.34%8.41%-7.23%36.76%-
Dividend Per Share0.760.680.600.600.600.600.600.54--
Dividend Growth11.76%13.33%0%0%0%0%11.11%---
Operating Cash Flow4,9734,5434,0053,2582,9422,6202,0112,0401,6911,498
Capital Expenditures-890-708-501-418-405-378-262-302-253-235
Free Cash Flow4,0833,8353,5042,8402,5372,2411,7491,7371,4381,263
Cash & Equivalents2,3992,1031,3357864521,3445,8318101,021926
Total Debt17,75218,99021,00816,62712,47214,56410,4877,1247,0282,137
Net Cash / Debt-15,353-16,887-19,673-15,841-12,020-13,221-4,657-6,314-6,007-1,211
Book Value29,67527,58625,41321,54021,35020,54816,85615,46515,03815,361
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Thermo Fisher Scientific, Inc.
Country United States
Employees 75,000
CEO Marc N. Casper

Stock Information

Ticker Symbol TMO
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NYSE: TMO


Thermo Fisher Scientific provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrödinger, Inc. to expand structure-based drug discovery to novel targets using Cryo-EM; and an agreement with Daiichi Sankyo to co-develop a companion diagnostic. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.